BC Week In Review | Oct 26, 2009
Clinical News

ARCHITECT Anti-CCP assay regulatory update

FDA granted 510(k) clearance for Axis-Shield's antibody cyclic-citrulinated peptide (anti-CCP) assay to aid in the diagnosis of rheumatoid arthritis for use on the Architect i1000SR and i2000SR immunoassay systems from Abbott Laboratories (NYSE:ABT, Abbott Park,...
Items per page:
1 - 1 of 1